Skip to cookie consent Skip to main content

Research Spotlight: Global Analysis Reveals Sharp Rise in Cancer Among People Under 50

5 minute read
Tomotaka Ugai, MD, PhD
Tomotaka Ugai, MD, PhD

Tomotaka Ugai, MD, PhD, of the Department of Pathology at Mass General Brigham, is the corresponding author of a paper published in Military Medical Research, “Diverging global incidence trends of early-onset cancers: comparisons with incidence trends of later-onset cancers and mortality trends of early-onset cancers.”

Q: How would you summarize your study for a lay audience?

We looked at cancer trends in adults under 50, known as early-onset cancers, which have been rising worldwide. Our study compared these trends to cancers diagnosed later in life and found that early-onset cancers are increasing faster for several cancer types. In some countries, cancers like colorectal and uterine are not only more common in younger adults, but deaths due to these cancer types are also increasing in younger adults. These patterns suggest that the rise is not just due to better detection, but reflects a real increase in disease burden in the younger population.

Q: What question were you investigating?

We wanted to study two things:

  • Are early-onset cancers increasing more quickly than cancers in older adults?
  • And, for some cancers, are both incidence and mortality rising at the same time?

Q: What methods or approach did you use?

We analyzed global cancer data from 2000 to 2017 using two major resources: the Cancer Incidence in Five Continents database and the World Health Organization mortality database. We calculated annual changes in early-onset cancer rates by type and country, and explored whether rising obesity in younger populations might be linked to these trends.

Q: What did you find?

We found that many cancers in younger adults are rising significantly across multiple regions worldwide, especially in developed countries. For women, cancers such as colorectal, cervical, pancreatic, and multiple myeloma showed the steepest increases in adults under 50 compared to the same cancers in older adults. For men, early-onset prostate, colorectal, and kidney cancers had the most dramatic growth. In some places, these increases were especially pronounced for colorectal cancer, where rates in younger adults went up by about 2% per year while rates in older adults stayed flat or even slightly declined.

Importantly, for certain cancers, such as uterine and colorectal, we saw both incidence and mortality rising together, which suggests that these trends are not just due to better detection.

We also found strong links between obesity and cancer: countries with higher obesity rates among younger people tended to have bigger increases in obesity-related cancers, including thyroid, kidney, and colorectal cancers. These patterns suggest that lifestyle factors, such as diet and physical activity, may play a major role in the growing burden of cancer among younger adults.

Q: What are the implications?

The steep increase in cancers among younger adults signals a major shift in global health patterns. It suggests that risk factors traditionally associated with older age — such as obesity, poor diet, and sedentary lifestyles — are now affecting people earlier in life. This trend could point to changes in environmental exposures, biological factors, or even generational differences in lifestyle habits.

While improved screening may explain part of the increase, the fact that mortality of colorectal cancer and uterine cancer is also rising in several countries means that these cancers are not just being detected earlier — they are causing real harm. This growing burden could strain healthcare systems, as younger patients often require long-term treatment and support. It also raises questions about prevention: how can we reduce risk factors earlier in life? Public health strategies may need to shift toward younger populations, focusing on diet, physical activity, and awareness of symptoms.

Ultimately, these findings highlight the urgency of understanding why these cancers are increasing and how to intervene before they become an even larger global challenge.

Q: What are the next steps?

There are several important directions for future research.

First, we need to examine these trends in more countries and regions to understand whether the patterns we observed are truly global. Second, our study could not account for details like cancer stage at diagnosis, tumor characteristics, or treatment differences, so future studies should include these factors to clarify what is driving the rise.

Third, we need to better understand the role of screening and early detection in these trends, since screening can both help and complicate interpretation of incidence data. Finally, more research is needed to uncover potential biological, environmental, and lifestyle factors that may explain why certain cancers are increasing among younger adults. These steps will help guide prevention strategies and inform public health policies.

Paper cited: Terashima, M., et al. “Diverging global incidence trends of early-onset cancers: comparisons with incidence trends of later-onset cancers and mortality trends of early-onset cancers.” Military Medical Research. DOI: 10.1186/s40779-025-00670-8

Funding: This work was supported by the Prevent Cancer Foundation Grant, Harvey V. Fineberg Cancer Prevention Fellowship, and Brigham and Women’s Hospital Faculty Career Development Award, an Investigator Initiated Grant from the American Institute for Cancer Research (AICR). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Disclosures: None.

Media contact

Elizabeth Murphy
Program Director, External Communications

About Mass General Brigham

Mass General Brigham is an integrated academic health care system, uniting great minds to solve the hardest problems in medicine for our communities and the world. Mass General Brigham connects a full continuum of care across a system of academic medical centers, community and specialty hospitals, a health insurance plan, physician networks, community health centers, home care, and long-term care services. Mass General Brigham is a nonprofit organization committed to patient care, research, teaching, and service to the community. In addition, Mass General Brigham is one of the nation’s leading biomedical research organizations with several Harvard Medical School teaching hospitals. For more information, please visit massgeneralbrigham.org.